Author

Valeria Bonfante

Observed names: BONFANTE V, V Bonfante, V. Bonfante, VALERIA BONFANTE

Institution: Fondazione IRCCS Istituto Nazionale dei Tumori

Observed institutions: University of Verona, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, National and Kapodistrian University of Athens, Casa Sollievo della Sofferenza, University Hospital Cologne, Fondazione IRCCS Istituto Nazionale dei Tumori, Klinikum Chemnitz, IRCCS Humanitas Research Hospital

OpenAlex ID: A5025152199

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

2011 · Simonetta Viviani, Pier Luigi Zinzani, et al. · New England Journal of Medicine · 421

PDF

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.

1987 · A Santoro, G Bonadonna, et al. · Journal of Clinical Oncology · 377

Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD

1985 · S. Viviani, A. Santoro, et al. · European Journal of Cancer and Clinical Oncology · 369

ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term Results

2004 · Gianni Bonadonna, Valeria Bonfante, et al. · Journal of Clinical Oncology · 337

PDF

Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's Disease

1982 · ARMANDO SANTORO, VALERIA BONFANTE, et al. · Annals of Internal Medicine · 233

Gemcitabine in the Treatment of Refractory Hodgkin’s Disease: Results of a Multicenter Phase II Study

2000 · A. Santoro, H. Bredenfeld, et al. · Journal of Clinical Oncology · 229

Alternating Drug Combinations in the Treatment of Advanced Hodgkin's Disease

1982 · Armando Santoro, Gianni Bonadonna, et al. · New England Journal of Medicine · 211

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.

1997 · V Bonfante, A Santoro, et al. · Journal of Clinical Oncology · 179

Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.

1996 · S Viviani, G Bonadonna, et al. · Journal of Clinical Oncology · 170

Drugs ten years later: Epirubicin

1993 · G. Bonadonna, L. Gianni, et al. · Annals of Oncology · 154

PDF

CD20 Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin's Disease: Associations With Presenting Features and Clinical Outcome

2002 · George Z. Rassidakis, L. Jeffrey Medeiros, et al. · Journal of Clinical Oncology · 107

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

2002 · George Z. Rassidakis, L. Jeffrey Medeiros, et al. · Blood · 103

PDF

Serum Level of the Soluble Form of the CD30 Molecule Identifies Patients With Hodgkin's Disease at High Risk of Unfavorable Outcome

1998 · Gianpaolo Nadali, Luisa Tavecchia, et al. · Blood · 96

Phase II study of doxorubicin versus epirubicin in advanced breast cancer.

1986 · C Brambilla, A Rossi, et al. · PubMed · 94

Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's disease

1994 · L. Devizzi, A. Santoro, et al. · Annals of Oncology · 81

Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.

2003 · Marco Herling, George Z Rassidakis, et al. · PubMed · 80

Salvage chemotherapy in Hodgkin's disease

1990 · S. Viviani, A. Santoro, et al. · Annals of Oncology · 74

Primary and salvage chemotherapy in advanced Hodgkin's disease: The Milan Cancer Institute experience

1991 · Gianni Bonadonna, Armando Santoro, et al. · Annals of Oncology · 72

CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.

1986 · A Santoro, S Viviani, et al. · PubMed · 71

Toxic and Therapeutic Activity of 4'-Epi-Doxorubicin

1982 · Valeria Bonfante, Fabrizio Villani, et al. · Tumori Journal · 68

Survival in Hodgkin’s disease patients – Report of 25 years of experience at the Milan Cancer Institute

2005 · Gianni Bonadonna, Simonetta Viviani, et al. · European Journal of Cancer · 54

Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease

1997 · L. Devizzi, L. Maffioli, et al. · Annals of Oncology · 54

PDF

Preliminary phase I study of 4'-epi-adriamycin.

1979 · V Bonfante, G Bonadonna, et al. · PubMed · 53

Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.

1986 · A Santoro, S Viviani, et al. · PubMed · 51

Preliminary Clinical Experience with 4’-Epidoxorubicin in Advanced Human Neoplasia

1980 · V. Bonfante, G. Bonadonna, et al. · Recent results in cancer research/Recent Results in Cancer Research · 49

Works count: 85

Citation count: 4,568

H-index: 35

I10-index: 50